Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Halbritter

Showing results (61-70 of 106) with videos related to

Pageof 11
Sort By:
Clinical Kidney Journal|July 3, 2026
Primary hyperoxaluria type 1-current practice in the siRNA era: an ERA Genes & Kidney Working Group surveyMalte P Bartram, Giovambattista Capasso, Emilie Cornec-Le Gall, et al.
Kidney International Reports|August 19, 2024
Pathogenic PHIP Variants are Variably Associated With CAKUTJonathan de Fallois, Tobias Sieckmann, Ria Schönauer, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 21, 2016
Prevalence of Monogenic Causes in Pediatric Patients with Nephrolithiasis or NephrocalcinosisDaniela Anne Braun, Jennifer Ashley Lawson, Heon Yung Gee, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 2, 2025
Medical Management of Polycystic Liver Disease: A Position Statement From the European Reference Network on Hepatological DiseasesSophia Heinrich, Andreia Margarida Carvalho de Matos, Jordi Colmenero, et al.
Human Mutation|August 22, 2015
Targeted Resequencing of 29 Candidate Genes and Mouse Expression Studies Implicate ZIC3 and FOXF1 in Human VATER/VACTERL AssociationAlina C Hilger, Jan Halbritter, Tracie Pennimpede, et al.
Trials|February 14, 2024
HYDROchlorothiazide versus placebo to PROTECT polycystic kidney disease patients and improve their quality of life: study protocol and rationale for the HYDRO-PROTECT randomized controlled trialThomas Bais, Esther Meijer, Bart J Kramers, et al.
American Journal of Human Genetics|May 24, 2016
Mutations in SLC26A1 Cause NephrolithiasisHeon Yung Gee, Ikhyun Jun, Daniela A Braun, et al.
Kidney International|September 12, 2020
Cystinuria: clinical practice recommendationAude Servais, Kay Thomas, Luca Dello Strologo, et al.
Clinical Kidney Journal|July 2, 2026
Clinical impact of genetic testing in inherited kidney diseasesLea M Merz, Sarah Stopp, Ilona Krey, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 20, 2024
Deceased donor urinary Dickkopf-3 associates with future allograft function following kidney transplantationJonathan de Fallois, Anna Günzel, Christoph Daniel, et al.
Pageof 11

Showing results (61-70 of 106) with videos related to

Sort By:
Pageof 11
Clinical Kidney Journal|July 3, 2026
Primary hyperoxaluria type 1-current practice in the siRNA era: an ERA Genes & Kidney Working Group surveyMalte P Bartram, Giovambattista Capasso, Emilie Cornec-Le Gall, et al.
Kidney International Reports|August 19, 2024
Pathogenic PHIP Variants are Variably Associated With CAKUTJonathan de Fallois, Tobias Sieckmann, Ria Schönauer, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 21, 2016
Prevalence of Monogenic Causes in Pediatric Patients with Nephrolithiasis or NephrocalcinosisDaniela Anne Braun, Jennifer Ashley Lawson, Heon Yung Gee, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 2, 2025
Medical Management of Polycystic Liver Disease: A Position Statement From the European Reference Network on Hepatological DiseasesSophia Heinrich, Andreia Margarida Carvalho de Matos, Jordi Colmenero, et al.
Human Mutation|August 22, 2015
Targeted Resequencing of 29 Candidate Genes and Mouse Expression Studies Implicate ZIC3 and FOXF1 in Human VATER/VACTERL AssociationAlina C Hilger, Jan Halbritter, Tracie Pennimpede, et al.
Trials|February 14, 2024
HYDROchlorothiazide versus placebo to PROTECT polycystic kidney disease patients and improve their quality of life: study protocol and rationale for the HYDRO-PROTECT randomized controlled trialThomas Bais, Esther Meijer, Bart J Kramers, et al.
American Journal of Human Genetics|May 24, 2016
Mutations in SLC26A1 Cause NephrolithiasisHeon Yung Gee, Ikhyun Jun, Daniela A Braun, et al.
Kidney International|September 12, 2020
Cystinuria: clinical practice recommendationAude Servais, Kay Thomas, Luca Dello Strologo, et al.
Clinical Kidney Journal|July 2, 2026
Clinical impact of genetic testing in inherited kidney diseasesLea M Merz, Sarah Stopp, Ilona Krey, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|September 20, 2024
Deceased donor urinary Dickkopf-3 associates with future allograft function following kidney transplantationJonathan de Fallois, Anna Günzel, Christoph Daniel, et al.
Pageof 11